VAM
FLNA

Visium Asset Management’s Filana Therapeutics FLNA Stock Holding History

Visium Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-142,857
Closed -$2.21M – 853
2013
Q2 		$2.21M Buy
+142,857
New +$3.02M 0.05% 221

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Visium Asset Management's FLNA Position: Q2 2015 in Review

Visium Asset Management sold out of Filana Therapeutics (FLNA) in Q2 2015, closing a stake of 621,429 shares — an estimated $8.22M sold.

Visium Asset Management first reported a position in FLNA in Q2 2013 and held it in 8 quarters. The position peaked at $25M in Q2 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q2 2015.

  • Visium Asset Management reported no remaining Filana Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Visium Asset Management sold 621,429 Filana Therapeutics shares in Q2 2015, an estimated $8.22M.
  • Visium Asset Management first reported a position in Filana Therapeutics in Q2 2013 and held it in 8 quarters.
  • Visium Asset Management's Filana Therapeutics position peaked at $25M in Q2 2014.
  • 66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2015.

Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.